In 2023, Carlos V. Paya earned $1.13M in total compensation at Vaxcyte, Inc., including $640.00K salary and $480.00K bonus. Most recently acquired 2,500 shares in Dec 2024. Currently holds stock worth $643.26K. Has donated $250.82K in stock to charitable causes. 4+ years at the helm of Vaxcyte, Inc..
Compensation History
Annual executive compensation data for Carlos V. Paya, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.13M
Salary
$640.00K
Bonus
$480.00K
Other
$14.48K
Salary
$640.00KBoard Justification
The compensation philosophy emphasizes performance-based pay, aligning executive compensation with company performance and market benchmarks to attract and retain top talent.
Bonus
$480.00KBoard Justification
The annual performance-based bonus for 2023 was based on the achievement of corporate goals, with a payout of 125% of target due to solid performance against these goals.
Other Compensation
$14.48KBoard Justification
Other compensation includes life insurance premiums and 401(k) matching contributions.
Restricted Stock
Board Justification
No stock awards were reported as vested in 2023 for Carlos V. Paya.
Performance Metrics
The performance metrics for the CEO's compensation in 2023 were based on achieving specific corporate goals related to the company's vaccine development programs.
Carlos V. Paya
CEO of Vaxcyte, Inc.
Sector of Economy
Healthcare
CEO of Vaxcyte, Inc. for
4 years 1 month (Oct 2021 - Present)
Previous Experience
Extensive experience in the biopharmaceutical industry, former CEO of a biotechnology company.
Other Vaxcyte, Inc. CEOs
Holdings
Track Carlos V. Paya's stock holdings and portfolio value over time.
Charitable Transactions
5,625 shares
PCVX
Recent Charitable Transactions
2,500 shares
PCVX
Dec 6, 2024
Charity
3,125 shares
PCVX
Nov 9, 2023
Charity
Insider Trading
Carlos V. Paya's recent stock transactions, purchases, and sales filed with the SEC.
2,500 shares
PCVX
Dec 6, 2024
Received
2,500 shares
PCVX
Dec 6, 2024
Charity
1,550 shares
PCVX
Jun 6, 2024
Received
3,125 shares
PCVX
Nov 9, 2023
Received
3,125 shares
PCVX
Nov 9, 2023
Charity
26,376 shares
LAB
Jun 14, 2023
Received
2,500 shares
PCVX
Jun 13, 2023
Received
30,914 shares
LAB
Jun 15, 2022
Received
3,125 shares
PCVX
Jun 1, 2022
Received
Rivals
Compare Carlos V. Paya with competitor CEOs and industry peers.